August 19, 2016 Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers for ophthalmology and life sciences. Norris’ first-half numbers for Medtech start-ups...
August 11, 2016 ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build...
August 4, 2016 Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and start-ups, now leads what looks to be a new leader...
July 27, 2016 Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San Francisco – helped launch a “moonshot” that would eventually...
July 21, 2016 Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how...
July 14, 2016 Eric Timko, the former CEO of Blue Belt, shares how the company used MAKO’s wake to build a market for its surgical robot and sell...
July 7, 2016 The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO...
June 30, 2016 Gilde Healthcare Partner Geoff Pardo shares how the firm will invest its new $250 million in health care companies, including Medtech.
June 23, 2016 Julie Allen, principal of Allen Partners, shares insights on how Medtech executives must work to find the right fit and how companies can build their...